ATRA Atara Biotherapeutics Inc.

$-100%

444,208 Shares Traded
1,184,797 Average Volume (last 30 days)

as of February 23, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $210.18 million
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-137.02%
If Intiated One Month Ago, Shorts Have Realized a Return of:-28.64%
If Initiated Five Days ago, Shorts Have Realized a Return of:8.82%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 16.86%
Short Interest4.82 million
Float28.56 million
Short Ratio3.45
Market Cap$1.31 billion
Market Maker ActivityDaily Short Volume

News

02-15-2018
Premarket Losers as of 9:05 am (2/15/2018) (SeekingAlpha)
02-15-2018
Premarket analyst action - healthcare (SeekingAlpha)
02-14-2018
Tracking Seth Klarman's Baupost Group Holdings - Q4 2017 Update (SeekingAlpha)
02-07-2018
Spectrum Pharmaceuticals: What The Positive ADVANCE Study Entails? (SeekingAlpha)
01-31-2018
BioSci Rounds Report For Jan. 30, 2018 (SeekingAlpha)
01-30-2018
BioSci Rounds Report (Edition 1 Volume 3): Jan. 29, 2018 (SeekingAlpha)
01-24-2018
CAR-T Developers  Continue To Fly (SeekingAlpha)
01-24-2018
Atara's Recent Rally: Is The Enthusiasm Justified? (SeekingAlpha)
01-19-2018
Juno Therapeutics: What The Celgene Potential Acquisition Foretells (SeekingAlpha)
01-19-2018
Premarket Gainers as of 9:05 am (1/19/2018) (SeekingAlpha)


Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 96.9%

Earnings Stats

PE Ratio -12.36
Dividend Yield 0%
Peer EarningsEarnings Calendar

Technicals

200 Day Moving Average $18.06
50 Day Moving Average $28.16
52 Week High $49.9
52 Week Low $11.8



Data provided for free by IEX. Questions? Read the FAQ